Mycoplasma species identification is based on biochemical, immunological, and molecular methods that require several days for accurate identification.
Mycoplasma infection causes severe problems in laboratory rodent colonies [1] .
The Mycoplasma species isolated from mice and rats, M. pulmonis [13] , M. arthritidis [6] , M. neurolyticum [7] , M. muris [12] , and M. collis [5] , have been associated with several disease manifestations. M. pulmonis is an especially common pathogen in mice and rats and the etiological agent of murine respiratory mycoplasmosis [11] . For diagnosis of M. pulmonis infection, serological testing, culture methods, and polymerase chain reaction (PCR) assays have been used [3] . The culture method is one of the most common and specific methods to detect bacteria; however, a laborious step is needed to identify the colonies [4] , such as morphological studies, reversion studies, or the sterol requirement and metabolism inhibition test. Recently, sequence analysis of the 16S rRNA gene has also been used as a simple method for identification of the bacteria [16] .
More recently, matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF MS) has been applied to analyze the protein composition and used for direct identification of pathogens in the culture agar and/or broth [8, 14, 15] .
However, there has been limited work thus far on the use of MALDI-TOF MS for the identification of pathogens in laboratory animals. We demonstrate that MALDI-TOF MS can be used in the clinical laboratory for rapid and accurate identification of M.
pulmonis from solid culture media.
M. pulmonis (strain m53) [9] , M. arthritidis (PG6, ATCC19611), and M. neurolyticum (type A, ATCC19988) were used to construct a database for MALDI-TOF MS. Media for cultivation of Mycoplasma strains have been described previously [4] .
Briefly, an agar medium containing 70 mL of PPLO broth (BD, MD, USA) supplemented with 10 mL of 25% (w/v) yeast extract, 20 mL of heat-inactivated horse serum (Invitrogen, CA, USA), 1 mL of 100,000 units of penicillin G, 1 mL of 2.5% thallium acetate, and 1.3% Bacto agar (BD, MD, USA) was used. The agar medium was incubated at 37C for 4 to 7 days in a humid chamber.
Four and 2 tracheal swabs were collected from the mice and rats, respectively. The animals were derived from different animal facilities. The swabs were inoculated on the PPLO agar and cultured for 4 days. Identification of isolates was performed by 16S rRNA sequence analysis.
To determine the 16S rRNA sequence of mycoplasma isolates, a region of the 16S rRNA sequence was amplified with conserved universal primers F (5-AAT GGG TGA GTA ACA CGT A-3) and R (5-TGT ACA AAA CCC GAG AAC GT-3), and the expected size of the PCR products was 1289 bp. The PCR products were directly sequenced using the Taq DyeDeoxy Terminator Cycle Sequencing Kit (Applied Biosystems, Inc., CA, USA). The sequences were compared with a DNA database using the DNA Data Bank of Japan homology search system (http://vip05.nig.ac.jp/index-e.html).
Identification of a colony on the PPLO agar plate was performed by depositing a thin smear of bacterial suspension on a MALDI steel plate. A saturated solution of α -cyano-4-hydroxycinnamic acid in 50% acetonitrile and 2.5% trifluoroacetic acid was applied to the bacterial smear and dried. Measurements were performed with a Microflex mass spectrometer (Bruker Daltonics, Wissembourg, France) using the FlexControl software (version 3.0). Mass spectra were acquired in a linear positive extraction mode ranging from 2,000 to 20,000 Da. The spectrum was imported into the BioTyper software (version 2.0; Bruker, Karlsruhe, Germany). The degree of spectral concordance is expressed as a logarithmic identification score and interpreted according to the manufacturer's instructions: scores > 2.00 indicated species identification with a high level of confidence.
The spectra of M. pulmonis, M. arthritidis, and M. neurolyticum are shown in Fig.   1 . Each peak represents the mass of an intact protein detected in the analysis, whereas the height of the peak depends on the amount of proteins measured. The spectrum peaks were different depending on each mycoplasma species.
The spectra of 6 isolates were compared with the results of the reference strains, M. pulmonis, M. arthritidis, and M. neurolyticum. A representative spectrum of an isolate identified as M. pulmonis (m53) is shown in Fig. 2 . As shown in Table 1 , high level identification (spectral scores > 2.00) was obtained for 5 isolates with M. pulmonis (m53). The sequence analysis of these 5 isolates showed high homology with M. pulmonis m53 (>97.0%). The 1 remaining isolate from the mice trachea was identified as M. neurolyticum (spectral scores > 2.00 with M. neurolyticum type A). The DNA sequence of the isolate was 100% homologous with M. neurolyticum type A. MALDI-TOF MS, which is sensitive and efficacious, has been applied to analyze the protein composition of bacteria [8, 14, 15] . The method provides an easy-to-handle system to identify different bacterial pathogens and is useful in the determination of bacterial species. Databases for bacterial cluster analysis have now been established, although most of the databases are for human pathogens. In this study, we applied the system to laboratory animal pathogens, and we developed an initial reference database of Mycoplasma species. M. pulmonis, M. arthritidis, and M. neurolyticum are the most common pathogens in laboratory mice and rats. M. pulmonis in particular is epizootic in conventional animal facilities [2, 10] . To date, M. pulmonis has been identified by morphological and biochemical analyses. The 16S rRNA sequence analysis is one of the most powerful tools to identify bacterial species, including Mycoplasma; however, the analysis is costly and it is time-consuming to obtain the results. An M. pulmonis smear was treated with a saturated solution of α-cyano-4-hydroxycinnamic acid in 50% acetonitrile and 2.5% trifluoroacetic acid before measurements by a Microflex mass spectrometer. Because the organisms can be inactivated by treating them with the acid, the spread of pathogens within diagnostic laboratories can be restricted.
In this study, we developed the Mycoplasma species database for laboratory animals. Six clinical isolates could be identified by MALDI-TOF MS directly from a colony on a PPLO agar plate in 20 min without any ambiguity, and the results were completely consistent with sequence analysis. Once a MALDI-TOF MS database of a bacterial species is established, any isolates can be identified using the database. One of the 6 isolates was identified as M. neurolyticum. The mouse infected with M. neurolyticum showed no clinical signs, and only one colony was obtained on the PPLO agar. Using traditional phenotype-based diagnostic methods, the propagation step by PPLO broth was required to identify the bacteria from a colony. The serial passage of the Mycoplasma strains did not affect the MALDI-TOF MS results (data not shown).
On the other hand, the results from the liquid medium (PPLO broth) were not as good as those obtained from the agar medium (data not shown). The materials in the broth, such as horse serum or yeast extract, might have interfered with the analysis.
Identification of Mycoplasma from liquid growth media should be studied for using of this technology.
It is reported that M. pulmonis is closely related to M. agassizzii, which is isolated from desert tortoises by using 16S rRNA sequence analysis. We didn't compare the MALDI-TOF MS spectrum of M. agassizzii with that of M. pulmonis, because the purpose of this study was to identify murine mycoplasma species.
In conclusion, our results indicate that identification of M. pulmonis using MSLDI-TOF MS was consistent with a molecular method of Mycoplasma identification.
Furthermore, the identification of the bacteria by MALDI-TOF MS was clearly much more rapid than that by molecular methods, and MALDI-TOF is more cost-effective than the traditional methods, such as morphological studies, the metabolism inhibition test, and the immunological test. The current database generated by the results of the MALDI-TOF MS method for laboratory animals needs to be expanded. Once the database is more fully developed, we believe that MALDI typing will provide a suitable tool for diagnosing laboratory animal pathogens. 
